19-192 - Human Milk for Congenital Gastrointestinal Disorders
Status: openEffects of an Exclusive Human Milk Diet on Enteral Feeding Outcomes of Neonates with Congenital Gastrointestinal Disorders
Treatment for Neonates with Congenital Gastrointestinal Disorders
Contact Us
If you have questions about this trial or are interested in participating, please contact this Clinical Trial’s Coordinator by phone at 251-415-1088 or by email at edean@health.southalabama.edu.
Description
The purpose of this study is to determine whether or not an exclusive human milk diet, as compared to diets including formula, will be of benefit to infants who were born with congenital gastrointestinal disorders (CGD). The trial is designed to compare the time to full enteral feeds and days on parenteral nutrition in neonates with CGD who receive an exclusive human milk diet (EHMD), compared with those receiving partial and non-human milk diets, while hospitalized in the neonatal intensive care unit. It will also compare peak conjugated bilirubin levels, episodes of sepsis, feeding tolerance, feeding interruptions, episodes of necrotizing enterocolitis, hospital length of stay, and death between CGD neonates who receive EHMD versus partial and formula feeding, while hospitalized in the NICU.
Providers Associated With This Trial
Principle Investigator
![Fabien Eyal]()
View ProfileFabien G. Eyal, M.D., Ph.DNeonatologistLouise Lenoir Locke Professor of Neonatology; Chief of the Division of Neonatology; Professor of Pediatrics
